Huennekens R Scott
SEC-identified person · CIK 1365493 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Quidelortho Corp QDEL | Director | filed 2024–2026 |
| Neuropace Inc NPCE | Director | filed 2025–2026 |
| Envista Holdings Corp NVST | Director | filed 2019–2026 |
| Hyperfine, Inc. HYPR | Director | filed 2021–2024 |
| Nuvasive INC NUVA | Director | filed 2018–2023 |
| Acutus Medical, Inc. AFIB | Director | filed 2020–2023 |
| Viewray, Inc. VRAY | Director | filed 2018–2020 |
| Reva Medical, Inc. RVA:AX | Director | filed 2015–2017 |
| Endochoice Holdings, Inc. GI | Director | filed 2015–2016 |
| Bellerophon Therapeutics, Inc. BLPH | Director | filed 2015–2015 |
| Volcano Corp VOLC | Director · President and CEO | filed 2006–2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.